<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00668174</url>
  </required_header>
  <id_info>
    <org_study_id>PATH - CA/AG69334-01A2,</org_study_id>
    <secondary_id>IR-4290</secondary_id>
    <nct_id>NCT00668174</nct_id>
  </id_info>
  <brief_title>Effect of Exercise on Sex Hormones in Postmenopausal Women</brief_title>
  <official_title>Physical Activity and Total Health Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fred Hutchinson Cancer Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fred Hutchinson Cancer Research Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goals of the study are to examine the effect in postmenopausal women of a one-year
      moderate intensity exercise intervention, as compared with a sedentary pattern (low-level
      stretching program), on: serum estrogens, androgens, sex hormone binding globulin, insulin,
      triglycerides, glucose, aromatase, FSH, LH, as well as parameters of body fat mass.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 1997</start_date>
  <completion_date type="Actual">December 2004</completion_date>
  <primary_completion_date type="Actual">December 2003</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum total estrone concentration</measure>
    <time_frame>Baseline, 3 month, 12-month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>serum total estradiol, free estradiol, estrone sulfate, testosterone, androstenedione, and sex hormone binding globulin (SHBG).</measure>
    <time_frame>baseline, 3 month, 12-month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary estrogen metabolite ratio (2-OHE1:16alpha-OHE1).</measure>
    <time_frame>Basline, 3 month, 12-month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adipose tissue stores: weight, body mass index, total fat mass, waist and hip circumferences and their ratio, and subcutaneous and intra-abdominal fat areas</measure>
    <time_frame>Baseline, 3 month, 12 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting serum concentrations of insulin, glucose, and triglycerides</measure>
    <time_frame>Baseline, 3 month, 12 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>Baseline, 3 month, 12 month</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">173</enrollment>
  <condition>Breast Cancer Prevention</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Exercise</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>Moderate intensity exercise, 5 days per week, 45 min per session, 50-70% max HR, divided into a 3-month individualized and 9-month maintenance period.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ages 55-75 years at first group meeting

          -  Physically able to undertake a moderate exercise program

          -  Sedentary activity pattern (exercising &lt; 2 times/week for 20 minutes at a level to
             produce sweating)

          -  Postmenopausal (not experiencing menstrual periods for the previous 12 months or FSH
             &gt;30 mIU/ml; for women who have had a hysterectomy, an FHS &gt;30 mIU/ml will classify
             them as postmenopausal)

          -  Body Mass Index (BMI) greater than 25.0

          -  Able to follow directions and fill out questionnaires, and exercise diaries and logs
             in English

          -  Agrees to be randomly assigned to either the exercise intervention or control group

          -  Gives informed consent to participate in all screening and study activities

          -  Able to come to the FHCRC for clinic visits and classes, to the UW Medical Center for
             CT scans, and to the UW NETT for measurements and instruction

        Exclusion Criteria:

          -  Plans to leave Western Washington within the follow-up period

          -  Using hormone replacement, tamoxifen, or oral contraceptives in past 6 months

          -  Currently having severe hot flashes (that might prompt participant to start hormone
             replacement therapy before the end of study)

          -  Current unstable thyroid disease or unstable dose of thyroid medications or TSH &gt;5.0
             IU/ml or &lt;0.5 IU/ml

          -  Invasive cancer in the past 10 years (except nonmelanotic skin cancer)

          -  Any other endocrinologic abnormality

          -  Breast, endometrial, ovarian, or melanoma cancer or carcinoma-in-situ at any time

          -  Morbidly obese (BMI &gt; 40)

          -  Current or planned use of corticosteroids

          -  Currently on or planning to enter a structured weight loss program or to take diet
             drugs

          -  Current use of certain other medications, such as any likely to interfere with
             adherence to an exercise program or likely to interfere with study outcomes

          -  Moderate to high alcohol intake (more than 2 drinks per day)

          -  Current smoker

          -  Diabetes mellitus (fasting hyperglycemia)

          -  Abnormal screening labs (hematocrit &lt; 32 or &gt; 48, white blood cells &lt; 3.0 or &gt; 15.0,
             potassium &lt; 3.5 or &gt; 5.0, fasting glucose &gt; 140, creatinine &gt; 2.0), or abnormalities
             on screening physical judged by study physicians to contraindicate participation in an
             exercise program

          -  Contraindications for entry into a training program118 including: unstable angina,
             uncontrolled hypertension (systolic &gt; 200, diastolic &gt; 100), orthostatic hypotension
             (&gt; 20), moderate/severe aortic stenosis, uncontrolled arrhythmia, uncontrolled
             congestive heart failure, third degree heart block, pericarditis, myocarditis,
             pulmonary/systemic embolism within the past 6 months, thrombophlebitis, ST
             displacement &gt; 3 mm at rest, history of cardiac arrest)

          -  Contraindications for exercise testing118 including: recent (within 6 months) cardiac
             event (MI, pulmonary edema, myocarditis, pericarditis), unstable angina, uncontrolled
             arrhythmia, third degree heart block, left bundle branch block, acute congestive
             failure, recent (within 6 months) pulmonary/systemic embolus, severe electrolyte
             abnormality

          -  Meets criteria to stop screening exercise test118 as decided by overseeing physician
             (Dr. Schwartz or McTiernan)

          -  volunteering in order to lose weight

          -  alcohol or drug abuse, significant mental illness (as assessed by study staff
             impression)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Fred Hutchinson Cancer Research Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Campbell PT, Wener MH, Sorensen B, Wood B, Chen-Levy Z, Potter JD, McTiernan A, Ulrich CM. Effect of exercise on in vitro immune function: a 12-month randomized, controlled trial among postmenopausal women. J Appl Physiol (1985). 2008 Jun;104(6):1648-55. doi: 10.1152/japplphysiol.01349.2007. Epub 2008 Apr 10.</citation>
    <PMID>18403448</PMID>
  </results_reference>
  <results_reference>
    <citation>Boynton A, Neuhouser ML, Sorensen B, McTiernan A, Ulrich CM. Predictors of diet quality among overweight and obese postmenopausal women. J Am Diet Assoc. 2008 Jan;108(1):125-30.</citation>
    <PMID>18155998</PMID>
  </results_reference>
  <results_reference>
    <citation>Tworoger SS, Sorensen B, Chubak J, Irwin M, Stanczyk FZ, Ulrich CM, Potter J, McTiernan A. Effect of a 12-month randomized clinical trial of exercise on serum prolactin concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):895-9.</citation>
    <PMID>17507612</PMID>
  </results_reference>
  <results_reference>
    <citation>Rhew I, Yasui Y, Sorensen B, Ulrich CM, Neuhouser ML, Tworoger SS, Chubak J, Bowen DJ, McTiernan A. Effects of an exercise intervention on other health behaviors in overweight/obese post-menopausal women. Contemp Clin Trials. 2007 Jul;28(4):472-81. Epub 2007 Jan 12.</citation>
    <PMID>17287149</PMID>
  </results_reference>
  <results_reference>
    <citation>Chubak J, McTiernan A, Sorensen B, Wener MH, Yasui Y, Velasquez M, Wood B, Rajan KB, Wetmore CM, Potter JD, Ulrich CM. Moderate-intensity exercise reduces the incidence of colds among postmenopausal women. Am J Med. 2006 Nov;119(11):937-42.</citation>
    <PMID>17071161</PMID>
  </results_reference>
  <results_reference>
    <citation>Bowen DJ, Fesinmeyer MD, Yasui Y, Tworoger S, Ulrich CM, Irwin ML, Rudolph RE, LaCroix KL, Schwartz RR, McTiernan A. Randomized trial of exercise in sedentary middle aged women: effects on quality of life. Int J Behav Nutr Phys Act. 2006 Oct 4;3:34.</citation>
    <PMID>17020620</PMID>
  </results_reference>
  <results_reference>
    <citation>Littman AJ, Vitiello MV, Foster-Schubert K, Ulrich CM, Tworoger SS, Potter JD, Weigle DS, McTiernan A. Sleep, ghrelin, leptin and changes in body weight during a 1-year moderate-intensity physical activity intervention. Int J Obes (Lond). 2007 Mar;31(3):466-75. Epub 2006 Aug 15.</citation>
    <PMID>16909130</PMID>
  </results_reference>
  <results_reference>
    <citation>Chubak J, Ulrich CM, Tworoger SS, Sorensen B, Yasui Y, Irwin ML, Stanczyk FZ, Potter JD, McTiernan A. Effect of exercise on bone mineral density and lean mass in postmenopausal women. Med Sci Sports Exerc. 2006 Jul;38(7):1236-44.</citation>
    <PMID>16826020</PMID>
  </results_reference>
  <results_reference>
    <citation>Mohanka M, Irwin M, Heckbert SR, Yasui Y, Sorensen B, Chubak J, Tworoger SS, Ulrich CM, McTiernan A. Serum lipoproteins in overweight/obese postmenopausal women: a one-year exercise trial. Med Sci Sports Exerc. 2006 Feb;38(2):231-9.</citation>
    <PMID>16531889</PMID>
  </results_reference>
  <results_reference>
    <citation>Chubak J, Tworoger SS, Yasui Y, Ulrich CM, Stanczyk FZ, McTiernan A. Associations between reproductive and menstrual factors and postmenopausal androgen concentrations. J Womens Health (Larchmt). 2005 Oct;14(8):704-12.</citation>
    <PMID>16232102</PMID>
  </results_reference>
  <results_reference>
    <citation>Frank LL, Sorensen BE, Yasui Y, Tworoger SS, Schwartz RS, Ulrich CM, Irwin ML, Rudolph RE, Rajan KB, Stanczyk F, Bowen D, Weigle DS, Potter JD, McTiernan A. Effects of exercise on metabolic risk variables in overweight postmenopausal women: a randomized clinical trial. Obes Res. 2005 Mar;13(3):615-25.</citation>
    <PMID>15833948</PMID>
  </results_reference>
  <results_reference>
    <citation>McTiernan A, Sorensen B, Yasui Y, Tworoger SS, Ulrich CM, Irwin ML, Rudolph RE, Stanczyk FZ, Schwartz RS, Potter JD. No effect of exercise on insulin-like growth factor 1 and insulin-like growth factor binding protein 3 in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):1020-1.</citation>
    <PMID>15824183</PMID>
  </results_reference>
  <results_reference>
    <citation>Irwin ML, McTiernan A, Baumgartner RN, Baumgartner KB, Bernstein L, Gilliland FD, Ballard-Barbash R. Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors. J Clin Oncol. 2005 Feb 1;23(4):774-82.</citation>
    <PMID>15681521</PMID>
  </results_reference>
  <results_reference>
    <citation>Foster-Schubert KE, McTiernan A, Frayo RS, Schwartz RS, Rajan KB, Yasui Y, Tworoger SS, Cummings DE. Human plasma ghrelin levels increase during a one-year exercise program. J Clin Endocrinol Metab. 2005 Feb;90(2):820-5. Epub 2004 Dec 7.</citation>
    <PMID>15585547</PMID>
  </results_reference>
  <results_reference>
    <citation>Irwin ML, Tworoger SS, Yasui Y, Rajan B, McVarish L, LaCroix K, Ulrich CM, Bowen D, Schwartz RS, Potter JD, McTiernan A. Influence of demographic, physiologic, and psychosocial variables on adherence to a yearlong moderate-intensity exercise trial in postmenopausal women. Prev Med. 2004 Dec;39(6):1080-6.</citation>
    <PMID>15539040</PMID>
  </results_reference>
  <results_reference>
    <citation>Chubak J, Tworoger SS, Yasui Y, Ulrich CM, Stanczyk FZ, McTiernan A. Associations between reproductive and menstrual factors and postmenopausal sex hormone concentrations. Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1296-301.</citation>
    <PMID>15298949</PMID>
  </results_reference>
  <results_reference>
    <citation>Frankenfeld CL, McTiernan A, Aiello EJ, Thomas WK, LaCroix K, Schramm J, Schwartz SM, Holt VL, Lampe JW. Mammographic density in relation to daidzein-metabolizing phenotypes in overweight, postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1156-62.</citation>
    <PMID>15247126</PMID>
  </results_reference>
  <results_reference>
    <citation>McTiernan A, Tworoger SS, Rajan KB, Yasui Y, Sorenson B, Ulrich CM, Chubak J, Stanczyk FZ, Bowen D, Irwin ML, Rudolph RE, Potter JD, Schwartz RS. Effect of exercise on serum androgens in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1099-105.</citation>
    <PMID>15247119</PMID>
  </results_reference>
  <results_reference>
    <citation>Aiello EJ, Yasui Y, Tworoger SS, Ulrich CM, Irwin ML, Bowen D, Schwartz RS, Kumai C, Potter JD, McTiernan A. Effect of a yearlong, moderate-intensity exercise intervention on the occurrence and severity of menopause symptoms in postmenopausal women. Menopause. 2004 Jul-Aug;11(4):382-8.</citation>
    <PMID>15243275</PMID>
  </results_reference>
  <results_reference>
    <citation>Tworoger SS, Chubak J, Aiello EJ, Yasui Y, Ulrich CM, Farin FM, Stapleton PL, Irwin ML, Potter JD, Schwartz RS, McTiernan A. The effect of CYP19 and COMT polymorphisms on exercise-induced fat loss in postmenopausal women. Obes Res. 2004 Jun;12(6):972-81.</citation>
    <PMID>15229337</PMID>
  </results_reference>
  <results_reference>
    <citation>Shade ED, Ulrich CM, Wener MH, Wood B, Yasui Y, Lacroix K, Potter JD, McTiernan A. Frequent intentional weight loss is associated with lower natural killer cell cytotoxicity in postmenopausal women: possible long-term immune effects. J Am Diet Assoc. 2004 Jun;104(6):903-12.</citation>
    <PMID>15175588</PMID>
  </results_reference>
  <results_reference>
    <citation>Atkinson C, Lampe JW, Tworoger SS, Ulrich CM, Bowen D, Irwin ML, Schwartz RS, Rajan BK, Yasui Y, Potter JD, McTiernan A. Effects of a moderate intensity exercise intervention on estrogen metabolism in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):868-74.</citation>
    <PMID>15159321</PMID>
  </results_reference>
  <results_reference>
    <citation>McTiernan A, Tworoger SS, Ulrich CM, Yasui Y, Irwin ML, Rajan KB, Sorensen B, Rudolph RE, Bowen D, Stanczyk FZ, Potter JD, Schwartz RS. Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. Cancer Res. 2004 Apr 15;64(8):2923-8.</citation>
    <PMID>15087413</PMID>
  </results_reference>
  <results_reference>
    <citation>Tworoger SS, Yasui Y, Vitiello MV, Schwartz RS, Ulrich CM, Aiello EJ, Irwin ML, Bowen D, Potter JD, McTiernan A. Effects of a yearlong moderate-intensity exercise and a stretching intervention on sleep quality in postmenopausal women. Sleep. 2003 Nov 1;26(7):830-6.</citation>
    <PMID>14655916</PMID>
  </results_reference>
  <results_reference>
    <citation>Irwin ML, Yasui Y, Ulrich CM, Bowen D, Rudolph RE, Schwartz RS, Yukawa M, Aiello E, Potter JD, McTiernan A. Effect of exercise on total and intra-abdominal body fat in postmenopausal women: a randomized controlled trial. JAMA. 2003 Jan 15;289(3):323-30.</citation>
    <PMID>12525233</PMID>
  </results_reference>
  <verification_date>November 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 25, 2008</study_first_submitted>
  <study_first_submitted_qc>April 25, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2008</study_first_posted>
  <last_update_submitted>November 26, 2012</last_update_submitted>
  <last_update_submitted_qc>November 26, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 28, 2012</last_update_posted>
  <responsible_party>
    <name_title>Anne McTiernan, MD, PhD</name_title>
    <organization>Fred Hutchinson Cancer Research Center</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

